Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOE-115 for Vasomotor Symptoms in Menopause
NCT06385795Phase 2Completed
- Sponsor
- Noema Pharma
- Start
- Apr 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cendifensine in vasomotor symptoms, menopause, sponsored by Noema Pharma. Started Apr 2024; status: completed.
02
Drugs
Cendifensine
03
Conditions
vasomotor symptomsmenopause
Beyond the preview
Go deeper on NCT06385795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06385795.